首页

Zhaoke Ophthalmology Partners with TSH Biopharm to Bring Innovative Presbyopia Therapy BRIMOCHOLTM PF to Taiwan Region

2025-12-08

266

Zhaoke Ophthalmology Donates HK$200,000 to the “Support Fund for Wang Fuk Court in Tai Po” to Assist with the Post-Tragedy Rescue Operations

2025-12-01

195

Zhaoke Ophthalmology Obtains IND Approval for its Second Back-of-Eye Drug PAN-90806 and Marketing Authorization for Epinastine HCl Eye Drop

2025-11-24

449

Zhaoke Ophthalmology Secures Second Partnership with PT Ferron for Commercialization in Indonesia for BRIMOCHOL™ PF

2025-11-06

876

Zhaoke Ophthalmology Announces Submission of a New Drug Application for BRIMOCHOLTM PF for the Treatment of Presbyopia to the MFDS in South Korea

2025-11-05

698

首页 1 2 3 4 5 尾页

Guangzhou Headquarters

Tel: 020-39062828

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

Wechat

Guangzhou Headquarters

Tel: 020-39062888

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

Wechat